Research Confirms Success of Herb For Diabetes Cntrol

Research Confirms Success Of Herb For Diabetes Control

CHICAGO, Nov. 15, Internet Wire -- In the first test of its kind in the US, Diabetes In Control.com has announced positive results of a controlled clinical trial on diabetics using Beta Fast® GXR® Glucose Balance, an extended release herbal dietary supplement. The trial investigated the glucose lowering effects by supplementing the diet with Beta Fast, thereby reducing HbA1c (glycosylated hemoglobin), a key measurement in diabetes management representing a 90-day average of blood sugar readings. Of 65 patients tested over the 90-day trial, Beta Fast reduced mean fasting glucose levels by 11 percent. Average post meal glucose levels showed a decline of 13 percent and HbA1c's dropped 6.8 percent (.6 point decline). In a subset of patients with the poorest control, results were more substantial. Pre-meal readings averaged an 18 percent decline, with post meal levels reduced by 28 percent. Corresponding HbA1c's declined 10 percent (1.1 actual points). Improved glucose control with Beta Fast enabled 16 percent of the participants to decrease their prescription medication usage. (Complete study available online www.alternativediabetes.com/html/incontrol.shtml With over 18,000 members, Diabetes In Control.com is one of the nation's largest organizations of diabetes health professionals. Members include diabetes educators, pharmacists, nurses, physicians and dieticians. The firm develops clinical protocols for testing diabetes related products, subsequently offering them for free to their members' patients. Members then enroll their patients in the studies, promoting patient involvement and as a result, improved diabetes care. The American Diabetes Association estimates that this year alone over 180,000 people will die from diabetes and over 800,000 new cases will be diagnosed. A chronic disease without a cure, diabetes is the nation's seventh leading cause of death. If not controlled daily by insulin injections or oral medications, diabetes can lead to limb amputations, impotence, kidney failure, cardiovascular disease and blindness. Informulab, maker of Beta Fast, markets the product to assist in the maintenance of healthy blood sugar levels in diabetics. The product is the subject of two other clinical trials now underway at Creighton University in Omaha, NE. Sold online at www.informulab.com and in over 3000 pharmacies nationwide, Beta Fast helps the body by balancing sugar levels, reducing sweetness cravings, and promoting healthy pancreatic function. Informulab is owned by Wen-Cin Marketing, Inc., publisher of www.alternativediabetes.com, a 1500 page web resource on complementary and alternative therapies in diabetes care.